Bio-Path Holdings (BPTH)
OTHER OTC:BPTH
Want to see BPTH full AI Analyst Report?
Total Valuation
Bio-Path Holdings has a market cap or net worth of $326.98K. The enterprise value is $789.98K.
Market Cap$326.98K
Enterprise Value$789.98K
Share Statistics
Bio-Path Holdings has 9,342,151 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,342,151
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio-Path Holdings’s return on equity (ROE) is 1.06 and return on invested capital (ROIC) is 107.59%.
Return on Equity (ROE)1.06
Return on Assets (ROA)-12.79
Return on Invested Capital (ROIC)107.59%
Return on Capital Employed (ROCE)1.02
Revenue Per Employee0.00
Profits Per Employee-867.40K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Path Holdings is ―. Bio-Path Holdings’s PEG ratio is 0.00075.
PE Ratio―
PS Ratio0.00
PB Ratio-0.06
Price to Fair Value-0.06
Price to FCF-0.30
Price to Operating Cash Flow-0.20
PEG Ratio0.00075
Income Statement
In the last 12 months, Bio-Path Holdings had revenue of 0.00 and earned -8.67M in profits. Earnings per share was -1.10.
Revenue0.00
Gross Profit-96.00K
Operating Income-8.33M
Pretax Income-8.67M
Net Income-8.67M
EBITDA-8.24M
Earnings Per Share (EPS)-1.10
Cash Flow
In the last 12 months, operating cash flow was -1.60M and capital expenditures 0.00, giving a free cash flow of -1.60M billion.
Operating Cash Flow-1.60M
Free Cash Flow-1.60M
Free Cash Flow per Share-0.17
Dividends & Yields
Bio-Path Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.63
52-Week Price Change-82.41%
50-Day Moving Average0.06
200-Day Moving Average0.09
Relative Strength Index (RSI)66.69
Average Volume (3m)24.92K
Important Dates
Bio-Path Holdings upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Bio-Path Holdings as a current ratio of 0.08, with Debt / Equity ratio of -5.63%
Current Ratio0.08
Quick Ratio0.08
Debt to Market Cap0.98
Net Debt to EBITDA-0.06
Interest Coverage Ratio-39.49
Taxes
In the past 12 months, Bio-Path Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bio-Path Holdings EV to EBITDA ratio is -0.11, with an EV/FCF ratio of -0.59.
EV to Sales0.00
EV to EBITDA-0.11
EV to Free Cash Flow-0.59
EV to Operating Cash Flow-0.59
Balance Sheet
Bio-Path Holdings has $0.00 in cash and marketable securities with $463.00K in debt, giving a net cash position of -$463.00K billion.
Cash & Marketable Securities$0.00
Total Debt$463.00K
Net Cash-$463.00K
Net Cash Per Share-$0.05
Tangible Book Value Per Share-$1.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Path Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast84.78%